IL288014A - Controlling inter-sample test substance variability in complex biological matrices - Google Patents

Controlling inter-sample test substance variability in complex biological matrices

Info

Publication number
IL288014A
IL288014A IL288014A IL28801421A IL288014A IL 288014 A IL288014 A IL 288014A IL 288014 A IL288014 A IL 288014A IL 28801421 A IL28801421 A IL 28801421A IL 288014 A IL288014 A IL 288014A
Authority
IL
Israel
Prior art keywords
intersample
controlling
complex biological
biological matrices
analyte variability
Prior art date
Application number
IL288014A
Other languages
English (en)
Hebrew (he)
Original Assignee
Somalogic Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Somalogic Inc filed Critical Somalogic Inc
Publication of IL288014A publication Critical patent/IL288014A/en

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6848—Methods of protein analysis involving mass spectrometry
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16C—COMPUTATIONAL CHEMISTRY; CHEMOINFORMATICS; COMPUTATIONAL MATERIALS SCIENCE
    • G16C20/00—Chemoinformatics, i.e. ICT specially adapted for the handling of physicochemical or structural data of chemical particles, elements, compounds or mixtures
    • G16C20/20—Identification of molecular entities, parts thereof or of chemical compositions

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Computing Systems (AREA)
  • Theoretical Computer Science (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
IL288014A 2019-05-17 2021-11-11 Controlling inter-sample test substance variability in complex biological matrices IL288014A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201962849212P 2019-05-17 2019-05-17
PCT/US2020/033033 WO2020236544A1 (en) 2019-05-17 2020-05-15 Controlling intersample analyte variability in complex biological matrices

Publications (1)

Publication Number Publication Date
IL288014A true IL288014A (en) 2022-01-01

Family

ID=71016636

Family Applications (1)

Application Number Title Priority Date Filing Date
IL288014A IL288014A (en) 2019-05-17 2021-11-11 Controlling inter-sample test substance variability in complex biological matrices

Country Status (11)

Country Link
US (1) US12480956B2 (enExample)
EP (1) EP3969900A1 (enExample)
JP (1) JP7748877B2 (enExample)
KR (1) KR20220009948A (enExample)
CN (1) CN113826170B (enExample)
AU (1) AU2020278570A1 (enExample)
BR (1) BR112021022532A8 (enExample)
CA (1) CA3140053A1 (enExample)
IL (1) IL288014A (enExample)
SG (1) SG11202111365QA (enExample)
WO (1) WO2020236544A1 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20220386905A1 (en) * 2021-03-02 2022-12-08 Pacific Diabetes Technologies Inc Signal processing algorithm for improving accuracy of a continuous glucose sensor and a combined continuous glucose sensor and insulin delivery cannula
GB202116626D0 (en) * 2021-11-18 2022-01-05 Fluidic Analytics Ltd Improvements in or relating to a method of analysing a component in a sample
CN117497037B (zh) * 2023-11-17 2024-08-16 上海倍谙基生物科技有限公司 一种基于广义线性模型的培养基组分敏感性分析方法

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69128350T2 (de) 1990-06-11 1998-03-26 Nexstar Pharmaceuticals Inc Nukleinsäureliganden
US5719273A (en) 1993-06-14 1998-02-17 Nexstar Pharmaceuticals, Inc. Palladium catalyzed nucleoside modifications methods using nucleophiles and carbon monoxide
US5945527A (en) 1996-05-30 1999-08-31 Nexstar Pharmaceuticals, Inc. Palladium catalyzed nucleoside modification methods using nucleophiles and carbon monoxide
US6242246B1 (en) 1997-12-15 2001-06-05 Somalogic, Inc. Nucleic acid ligand diagnostic Biochip
ES2371539T3 (es) * 2002-04-23 2012-01-04 Home Access Health Corporation Análisis cuantitativo de una muestra biológica de cantidad desconocida.
US7373256B2 (en) 2005-04-19 2008-05-13 Nicholson Jeremy K Method for the identification of molecules and biomarkers using chemical, biochemical and biological data
US7947447B2 (en) 2007-01-16 2011-05-24 Somalogic, Inc. Method for generating aptamers with improved off-rates
US7855054B2 (en) 2007-01-16 2010-12-21 Somalogic, Inc. Multiplexed analyses of test samples
MX2010000578A (es) 2007-07-17 2010-04-30 Somalogic Inc Metodo para generar aptameros con constantes de disociacion mejoradas.
US8260556B2 (en) 2008-08-21 2012-09-04 Bio-Rad Laboratories, Inc. Calibration surface method for determination on of analyte ratios
US9551703B2 (en) * 2009-08-04 2017-01-24 The Johns Hopkins University High precision quantitative assay composition and methods of use therefor
AU2011240677B2 (en) 2010-04-12 2015-05-14 Somalogic Operating Co., Inc. 5-position modified pyrimidines and their use
JP2013528379A (ja) 2010-05-21 2013-07-11 オームクス コーポレーション Ｐｓａ酵素活性アッセイによる癌の検出
CA2825196C (en) * 2011-01-21 2021-01-05 Theranos, Inc. Systems and methods for sample use maximization
EP3425090B1 (en) * 2014-02-18 2019-10-23 SomaLogic, Inc. Compositions and methods for detecting microorganisms
AU2016243656A1 (en) 2015-03-30 2017-11-09 Accelerate Diagnostics, Inc. Instrument and system for rapid microorganism identification and antimicrobial agent susceptibility testing

Also Published As

Publication number Publication date
SG11202111365QA (en) 2021-11-29
US20220260585A1 (en) 2022-08-18
CA3140053A1 (en) 2020-11-26
BR112021022532A2 (enExample) 2021-12-28
BR112021022532A8 (pt) 2022-10-11
JP2022532212A (ja) 2022-07-13
CN113826170A (zh) 2021-12-21
CN113826170B (zh) 2024-12-27
US12480956B2 (en) 2025-11-25
AU2020278570A1 (en) 2022-01-06
JP7748877B2 (ja) 2025-10-03
EP3969900A1 (en) 2022-03-23
KR20220009948A (ko) 2022-01-25
WO2020236544A1 (en) 2020-11-26

Similar Documents

Publication Publication Date Title
IL288014A (en) Controlling inter-sample test substance variability in complex biological matrices
SG11202103192RA (en) Il-12 heterodimeric fc-fusion proteins
IL286495A (en) Reducing inter-sample analysis variability in complex biological matrices
IL287318A (en) Materials and methods for the production of proteins
EP3735481A4 (en) METHODS OF MANUFACTURING A HIGH RESOLUTION DNA CHIP AND USING THE SAME IN SEQUENCING
SI3784047T1 (sl) Kvasni proteini
SG11202009930PA (en) Microfluidic method for single cell analysis
EP3740231A4 (en) PROGRAMMABLE PROTEIN CIRCUITS IN LIVING CELLS
GB201907242D0 (en) Dna methods etc ii
SI3731872T1 (sl) Postopek za zagotavljanje sestavka PEGiliranih beljakovin
IL268330A (en) Methods for determining interaction between biological cells
GB201913908D0 (en) Improvements in interaction analysis
IL281796A (en) Quantification of antibody in biological samples
HK40061957B (zh) 控制复杂生物基质中的样品间分析物可变性
HK40069493A (en) Controlling intersample analyte variability in complex biological matrices
HK40066203A (en) Reducing intersample analyte variability in complex biological matrices
GB201710524D0 (en) Controlling intersample analyte variability in complex biological matrices
GB2579810B (en) Assay Analysis
GB201817485D0 (en) Protein tablets
ZA202106718B (en) Novel selection marker-comprising cell line and uses thereof for protein production
SG11202112704TA (en) Nucleic acid analysis
GB201913953D0 (en) Multidimensional microfluidic protein characterisation
GB2583978B (en) Biological sample scanner
EP3802566A4 (en) PROTEINS AND THEIR USE IN NUCLEOTIDE BINDING
DK3615689T3 (en) Analytical methods and arrays for use in the same